Keenova Therapeutics plc Accretion Expense
Keenova Therapeutics plc reported Accretion Expense of $700.00 thousand for the 1-month period ending 2023-12-29, per its 10-K filed 2024-03-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2024-03-26
- Keenova Therapeutics plc accretion expense for the quarter ending 2023-09-29 was $38.10M, a 47.30% decline year-over-year.
- Keenova Therapeutics plc accretion expense for the quarter ending 2023-06-30 was $68.70M.
- Keenova Therapeutics plc accretion expense for the quarter ending 2023-03-31 was $69.90M.
- Keenova Therapeutics plc accretion expense for the quarter ending 2022-12-30 was $66.90M.
- Keenova Therapeutics plc accretion expense for fiscal 2021 was $0.00.
- Keenova Therapeutics plc accretion expense for fiscal 2020 was $0.00.
| Period end | Accretion Expense 0 month | Accretion Expense 1 month | Accretion Expense 3 month | Accretion Expense 5 month | Accretion Expense 6 month | Accretion Expense 9 month | Accretion Expense 10 month | Accretion Expense 12 month |
|---|---|---|---|---|---|---|---|---|
| 2023-12-29 | $700.00K 10-K · filed 2024-03-26 | |||||||
| 2023-11-14 | $176.70M 10-K · filed 2024-03-26 | |||||||
| 2023-09-29 | $38.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $106.80M derived: sum of 2 quarters · filed 2023-11-07 | $176.70M 10-Q · filed 2023-11-07 | $243.60M derived: sum of 4 quarters · filed 2024-03-26 | ||||
| 2023-06-30 | $68.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $138.60M 10-Q · filed 2023-08-09 | $205.50M derived: sum of 3 quarters · filed 2024-03-26 | $277.80M derived: sum of 4 quarters · filed 2024-03-26 | ||||
| 2023-03-31 | $69.90M 10-Q · filed 2023-05-09 | $136.80M derived: sum of 2 quarters · filed 2024-03-26 | $209.10M derived: sum of 3 quarters · filed 2024-03-26 | |||||
| 2022-12-30 | $66.90M derived: 10-K 6 month − 10-Q 3 month · filed 2024-03-26 | $139.20M 10-K · filed 2024-03-26 | ||||||
| 2022-09-30 | $72.30M 10-Q · filed 2023-11-07 | |||||||
| 2022-07-01 | $7.70M 10-Q · filed 2023-08-09 | |||||||
| 2022-06-16 | $0.00 10-K · filed 2024-03-26 | |||||||
| 2022-04-01 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-03-26 | ||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $0.00 10-K · filed 2024-03-26 | ||||||
| 2021-09-24 | $0.00 10-Q · filed 2022-11-08 | |||||||
| 2020-12-25 | $0.00 10-K · filed 2023-03-03 |